Key insights and market outlook
Indonesia's DPR Commission XI has raised concerns that new health regulations, particularly the Government Regulation No. 28/2024 and its derivative rules, may negatively impact businesses and state revenue if not properly aligned with existing policies. The regulations cover various aspects of national health transformation, including control of addictive substances, food safety, and healthcare workforce management. Commission members are worried about potential economic implications and the need for careful policy design to avoid adverse effects on strategic business sectors.
Indonesia's DPR Commission XI has expressed concerns that the recently introduced health regulations, particularly Government Regulation No. 28/2024 and its derivative rules, may have significant economic implications if not carefully designed. The commission is worried that these regulations could potentially pressure business performance and disrupt state revenue stability.
The new regulations cover a broad spectrum of national health transformation initiatives. Key areas include control of addictive substances (including tobacco and e-cigarettes), enhanced food safety measures, and more stringent management of healthcare professionals (including foreign workers). The regulations are part of the implementation of Law No. 17/2023 on Health, aiming to create a comprehensive national health framework.
The DPR Commission is calling for careful consideration and alignment of these new regulations with existing business practices and economic policies. The goal is to ensure that the health transformation agenda does not inadvertently harm Indonesia's economic landscape while still achieving its public health objectives.
New Health Regulation Introduction
Potential Business Impact Assessment